Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q2 2024 Earnings Call Transcript August 1, 2024
Alnylam Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.13, expectations were $-1.07.
Operator: Good day and thank you for standing by. Welcome to the Alnylam Pharmaceuticals Second Quarter 2024 Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a Q&A session. Please be advised that today’s conference is...
